Deciphera Pharmaceuticals Investor Relations Material
Latest events
Q4 2023
Deciphera Pharmaceuticals
Q1 2024
10 May, 2024
Corporate Presentation
8 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Deciphera Pharmaceuticals Inc
Access all reports
Deciphera Pharmaceuticals Inc is a biopharmaceutical company focused on the development of kinase inhibitors to treat cancer. The company conducts clinical research and commercializes small-molecule therapies for solid tumors and hematologic malignancies. It is headquartered in Waltham, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
DCPH
Country
🇺🇸 United States